Inhibition of Inflammation, Suppression of Matrix Metalloproteinases, Induction of Neurogenesis, and Antioxidant Property Make Bryostatin-1 a Therapeutic Choice for Multiple Sclerosis. (Record no. 28597338)

MARC details
000 -LEADER
fixed length control field 00878 a2200217 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517224837.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1663-9812
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3389/fphar.2018.00625
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Safaeinejad, Fahimeh
245 00 - TITLE STATEMENT
Title Inhibition of Inflammation, Suppression of Matrix Metalloproteinases, Induction of Neurogenesis, and Antioxidant Property Make Bryostatin-1 a Therapeutic Choice for Multiple Sclerosis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Frontiers in pharmacology
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 625 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bahrami, Soheyl
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Redl, Heinz
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Niknejad, Hassan
773 0# - HOST ITEM ENTRY
Title Frontiers in pharmacology
Related parts vol. 9
-- p. 625
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3389/fphar.2018.00625">https://doi.org/10.3389/fphar.2018.00625</a>
Public note Available from publisher's website

No items available.